Search In this Thesis
   Search In this Thesis  
العنوان
Evaluation of the Protective Effect of Quercetin Against Chlorpyrifos, Lead and Their Mixtures Induced Hepatotoxicity and
Nephrotoxicity in Male Rats =
المؤلف
Shawat, Rehab Mohamed Ibrahim,
هيئة الاعداد
باحث / Rehab Mohamed Ibrahim Shawat
مشرف / Hesham Zaki Ibrahim
مناقش / Abdullah M.A.Fouda
مناقش / Abdallah M. Hamed
الموضوع
Male Rats.
تاريخ النشر
2020.
عدد الصفحات
134 p. :
اللغة
الإنجليزية
الدرجة
ماجستير
التخصص
الكيمياء البيئية
تاريخ الإجازة
17/11/2020
مكان الإجازة
جامعة الاسكندريه - معهد الدراسات العليا والبحوث - Department of Environmental Studies.
الفهرس
Only 14 pages are availabe for public view

from 155

from 155

Abstract

Chlorpyrifos (CPF) is one of the most used OPs. It is used to control agriculture and household pests, flies and mosquitoes. CPF acts as an acetylcholinesterase inhibitor. Lead is a toxic metal that induces abroad range of physiological, biochemical and neurological dysfunctions in humans. Pb induces oxidative stress and disrupts the intracellular antioxidant balance through the generation of excess reactive oxygen species (ROS) in biological systems . *
Quercetin is a polyphenolic flavonoid compound. Moreover, owing to its high solubility and bioavailability, quercetin may also exhibit strong antioxidant activity after forming a complex or combining to form some novel preparations used for human health care.
The aim of the work was to explore whether quercetin affords protection against chlorpyrifos (CPF), lead acetate (PbA) and their mixture (CPF+PbA) induced hepatotoxicity and nephrotoxicity in male rats.
In this study eight groups (6 /each) of rats are assigned and treated as following:group I (control) was orally administered corn oil., group II was orally administered with a dose equal 50 mg/kg of body weight of quercetin., group III was orally administered with a dose equal 1.63 mg/kg of body weight of chlorpyrifos ., group IV was orally administered with a dose equal 10.8 mg/kg of body weight of lead acetate ., group V was orally administered with a dose equal 1.63 mg/kg of body weight of chlorpyrifos and 10.8 mg/kg of body weight of lead acetate,group VI was orally administered with a dose equal 1.63 mg/kg of body weight of chlorpyrifos and 50 mg/kg of body weight of quercetin., group VII was orally administered with a dose equal 10.8 mg/kg of body weight of lead acetate and 50 mg/kg of body weight of quercetin.